Faculty

Charles B. Nemeroff, MD, PhD Professor of Psychiatry Director, Institute for Early Life Adversity Research University of Texas Dell Medical School Austin, TX

Statement of Need

This video is a replay of a plenary session from the 11th Annual Chair Summit Master Class for Neuroscience Professional Development held in Ft. Lauderdale, FL on February 7-9, 2019.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Evaluate the role of pharmacogenomic testing in predicting antidepressant efficacy/response.

Financial Support

This activity is supported by CME Outfitters, LLC.

Target Audience

Physicians with an interest in psychiatry, neurology, and the neurosciences.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Nemeroff reports that he receives research grants from the National Institute of Health (NIH); and Stanley Medical Research Institute. He is a consultant for Bracket (Clintara); Fortress Biotech; Intra-Cellular Therapies, Inc.; Janssen Research & Development LLC; Magstim, Inc.; Navitor Pharmaceuticals, Inc.; Sumitomo Dainippon Pharma; Sunovion Pharmaceuticals Inc.; Taisho Pharmaceutical Inc.; Takeda Pharmaceuticals North America, Inc.; TC MSO, Inc.; and Xhale, Inc. He is a stockholder for AbbVie Inc.; Antares Pharma; BI Gen Holdings, Inc.; Celgene Corporation; Corcept Therapeutics; OPKO Health Inc.; Seattle Genetics, Inc.; TC MSO, Inc.; Trends in Pharma Development, LLC; and Xhale, Inc. He is on the scientific advisory board for American Foundation for Suicide Prevention (AFSP); Anxiety Disorders Association of America (ADAA); Bracket (Clintara); Brain & Behavior Research Foundation (BBRF); Laureate Institute for Brain Research, Inc.; Skyland Trail; and Xhale, Inc. He is on the Board of Directors for American Foundation for Suicide Prevention (AFSP); Anxiety Disorders Association of America (AADA); and GratitudeAmerica, Inc. He has income sources or equity of $10,000 or more from American Psychiatric Publishing; Bracket (Clintara); CME Outfitters, LLC; EMA Wellness; Intra-Cellular Therapies, Inc.; Magstim, Inc.; Takeda Pharmaceuticals North America, Inc.; and Xhale, Inc. He holds patents for Method and devices for transdermal delivery of lithium (US 6,375,990B1); Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (US 7,148,027B2); Compounds, Compositions, Methods of Synthesis, and Methods of Treatment (CRF Receptor Binding Ligand) (US 8,511,996B2).

Howard Bliwise, MD (peer reviewer) has no disclosures to report.

Kashemi D. Rorie, PhD (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS(877.263.7767).

CHV-083-080219-00